BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Business

  DNA 2.0, Inc. Announces Opening of European Office

  February 7, 2008

   · 

  1 min read
• Business

  digiMedical Solutions, Inc.™ Appoints David Happe to digiMedical Board of Directors

  February 7, 2008

   · 

  1 min read
• Pharm Country

  Cleveland Biolabs Inc. CEO to Share Ongoing Development Strategy at Biotechnology Industry Organization (BIO) CEO and Investor Conference

  February 7, 2008

   · 

  1 min read
• Drug Development

  Transdel Pharmaceuticals, Inc. Submits to the FDA the Phase 3 Clinical Study of Ketotransdel(TM) for the Treatment of Acute Pain

  February 7, 2008

   · 

  1 min read
• Business

  Forbes Medi-Tech Inc. Forecasts Strong Revenue Growth in 2008

  February 7, 2008

   · 

  1 min read
• Business

  Recordati S.p.A Reports Growth in 2007

  February 7, 2008

   · 

  1 min read
• Business

  Biophan Technologies, Inc. Names Harold Gubnitsky to Board of Directors

  February 7, 2008

   · 

  1 min read
• Business

  Smith & Nephew plc Announces 2007 Preliminary Results

  February 7, 2008

   · 

  1 min read
• Drug Development

  Avantogen Oncology, Inc. Release: Phase 2 Trial of RP101 in Late-Stage Pancreatic Cancer Patients Initiated by SciClone Pharmaceuticals, Inc.

  February 7, 2008

   · 

  1 min read
• Drug Development

  Theratechnologies Inc. Presents Additional Results From its Tesamorelin 52-Week Phase 3 Study at the Conference on Retroviruses and Opportunistic Infections

  February 7, 2008

   · 

  1 min read